Part of US based
Semler Group of Companies,
in business since 1946


YOU ARE HERE: Home Clinical Development Service Overview Consultation for Clinical Development Strategy
Consultation for Clinical Development Strategy

Semler Research Center provides access to rich & comprehensive intellectual capital accrued through experience gathered over decades for international NDA and ANDA submissions. Our scientific team is fully vested in providing high-quality and cost-sensitive solutions required for each proposed pathway.

Our clinical development plans are based on in-depth regulatory and clinical feasibilities conducted both internally (by consulting highly qualified pharmaceutical, clinical and regulatory personnel available in-house) and externally, through formal and informal discussions with regulatory bodies, clinical thought leaders and research institutions.

Clinical development plans proposed for:

  • Therapeutic equivalence studies in dermatology and ophthalmology for ANDA submissions
  • Patient pharmacokinetic (bioequivalence) studies in oncology and ophthalmology
  • Post-marketing studies in oncology and cardiovascular diseases
  • Registration studies for multiple products in neurology, hepatology and infectious diseases
  • Medical device for wound healing
  • Herbal and nutritional products for various indications




About This Service

SRC offers comprehensive Phase I-IV services for drugs, devices & diagnostics.  The team is well-entrenched in regulated market requirements & GCP. Our collective goal is to shrink your time-to-market through superior scientific expertise and trial management innovation.